These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 23938353)
1. Myasthenia gravis: new therapeutic approaches based on pathophysiology. Lewis RA J Neurol Sci; 2013 Oct; 333(1-2):93-8. PubMed ID: 23938353 [TBL] [Abstract][Full Text] [Related]
4. Outcome after Robotic-Assisted Thymectomy in Children and Adolescents with Acetylcholine Receptor Antibody-Positive Juvenile Myasthenia Gravis. Della Marina A; Kölbel H; Müllers M; Kaiser O; Ismail M; Swierzy M; Rueckert JC; Schara U Neuropediatrics; 2017 Aug; 48(4):315-322. PubMed ID: 28628938 [No Abstract] [Full Text] [Related]
13. Clinical features of patients with Myasthenia gravis from the Henan province, China. Gao F; Zhao X; Zhang J; Cui X; Zhang Y; Li Q; Liu P; Fang H; Du Y; Zhang Q; Yang J; Zhang Y Muscle Nerve; 2016 May; 53(5):711-6. PubMed ID: 26403759 [TBL] [Abstract][Full Text] [Related]
14. Myasthenia gravis crisis. Bershad EM; Feen ES; Suarez JI South Med J; 2008 Jan; 101(1):63-9. PubMed ID: 18176295 [TBL] [Abstract][Full Text] [Related]
15. Overview of myasthenia gravis. Arora Y; Li Y Hosp Pract (1995); 2013; 41(4):40-50. PubMed ID: 24145588 [TBL] [Abstract][Full Text] [Related]
16. Myasthenia gravis: immunological mechanisms and immunotherapy. Lewis RA; Selwa JF; Lisak RP Ann Neurol; 1995 May; 37 Suppl 1():S51-62. PubMed ID: 8968217 [TBL] [Abstract][Full Text] [Related]
17. IVIG Versus PLEX in the Treatment of Worsening Myasthenia Gravis: What is the Evidence?: A Critically Appraised Topic. Dhawan PS; Goodman BP; Harper CM; Bosch PE; Hoffman-Snyder CR; Wellik KE; Wingerchuk DM; Demaerschalk BM Neurologist; 2015 May; 19(5):145-8. PubMed ID: 25970838 [TBL] [Abstract][Full Text] [Related]
18. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child. Saulat B; Maertens P; Hamilton WJ; Bassam BA Neurology; 2007 Aug; 69(8):803-4. PubMed ID: 17709714 [No Abstract] [Full Text] [Related]
19. Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis. Lagoumintzis G; Zisimopoulou P; Kordas G; Lazaridis K; Poulas K; Tzartos SJ Autoimmunity; 2010 Aug; 43(5-6):436-45. PubMed ID: 20187712 [TBL] [Abstract][Full Text] [Related]
20. Current and future therapies for myasthenia gravis. Yi Q; Lefvert AK Drugs Aging; 1997 Aug; 11(2):132-9. PubMed ID: 9259176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]